Skip to main content
Download PDF

MSCs promote the efferocytosis of large peritoneal macrophages to eliminate ferroptotic monocytes/macrophages in the injured endometria

Stem Cell Research & Therapy volume 15, Article number: 127 (2024) Cite this article

Abstract

Background

Endometria are one of the important components of the uterus, which is located in the peritoneal cavity. Endometrial injury usually leads to intrauterine adhesions (IUA), accompanied by inflammation and cell death. We previously reported that both the endometrial ferroptosis was increased and monocytes/macrophages were involved in endometrial injury of IUA. Large peritoneal macrophages (LPMs) are recently reported to migrate into the injured tissues and phagocytose dead cells to repair the tissues. We previously demonstrated that mesenchymal stromal cells (MSCs) had made excellent progress in the repair of endometrial injury. However, it is unclear whether MSCs regulate the LPM efferocytosis against ferroptotic monocytes/macrophages in the injured endometria.

Methods

Here, endometrial injury in IUA mouse model was conducted by uterine curettage and LPS injection surgery and the samples were collected at different times to detect the changes of LPMs and ferroptotic monocytes/macrophages. We conducted LPMs depletion assay in vivo and LPMs and Erastin-induced ferroptotic THP-1 cells coculture systems in vitro to detect the LPM efferocytosis against ferroptotic monocytes/macrophages. The IUA model was treated with MSCs, and their effects on LPMs and endometrial repair were analyzed. Flow cytometry, western blotting, quantitative real-time PCR, immunohistochemical analysis, ELISA, and RNA-sequencing were performed.

Results

We found that LPMs migrated to the injured uteri in response to the damage in early phase (3 h), and sustained to a later stage (7 days). Astonishingly, we found that ferroptotic monocytes/macrophages were significantly increased in the injured uteri since 12 h after injury. Moreover, LPMs cocultured with Erastin-induced ferroptotic THP-1 cells in vitro, efferocytosis of LPMs against ferroptotic monocytes/macrophages was emerged. The mRNA expression profiles revealed that LPM efferocytosis against ferroptotic monocytes/macrophages was an induction of glycolysis program and depended on the PPARγ-HK2 pathway. Importantly, we validated that MSCs promoted the efferocytic capability and migration of LPMs to the injured uteri via secreting stanniocalcin-1 (STC-1).

Conclusion

The data collectively demonstrated first the roles of LPMs via removal of ferroptotic monocytes/macrophages and provided a novel mechanism of MSCs in repairing the endometrial injury.

Graphical Abstract

Background

Endometrial injury due to repeated intrauterine operations usually lead to intrauterine adhesions (IUA), which is a common syndrome of uterine infertility patients, accompanied by inflammation and cell death [1, 2]. Moderate-to-severe IUA may cause infertility of women within reproductive age. Endometrium is one of the important components of the uterus, which located in the peritoneal cavity. Current studies have reported that under physiological conditions, there are two kinds of macrophage populations in the peritoneal cavity of mammals, namely CD11b+ F4/80hi CD102+, large peritoneal macrophages (LPMs) and CD11b+ F4/80lo MHCII+, small peritoneal macrophages (SPMs) [3,4,5,6]. Research has established that LPMs not only fulfill peritoneal homeostatic functions, but are also involved in repair of tissue damage caused by inflammation and infection. In response to injury in the peritoneal cavity such as liver [7], or the pericardial cavity such as heart [8], LPMs can rapidly migrate into afflicted tissues and fulfill an essential role in the rapid clearance of the mass of cellular death and debris, promote an anti-inflammatory phenotype and help inflammation resolution [9]. However, whether LPMs can migrate into the uteri to phagocytose dead cells effectively under endometrial injury remains unknown.

We and other authors previously reported that ferroptosis occurred in the injured endometria to promote endometrial fibrosis in IUA [10, 11]. Ferroptosis is a novel form of oxidative cell death, which is regulated by glutathione peroxidase 4 (GPX4) and caused by iron-dependent oxidative damage [12, 13]. Moreover, ferroptosis in macrophages has been reported in several inflammation-related diseases [14,15,16]. For example, STING-regulated macrophage ferroptosis promoted sepsis-induced intestinal injury [14]. Phagocytosis of JAK2VF RBCs by plaque macrophages promoted ferroptosis that exacerbated atherosclerosis [15]. ACSL4 inhibition prevented macrophage ferroptosis and alleviated fibrosis in bleomycin-induced systemic sclerosis model [16]. Our previous studies have revealed that phenotypically and functionally distinct macrophages such as CX3CR1+ monocytes/macrophages or CD301+ macrophages promoted the differentiation of endometrial stromal cells into myofibroblasts and resulted in extracellular matrix accumulation, which drove inflammation and endometrial fibrosis in IUA [17, 18]. But it remains unknown whether ferroptosis occurred in monocytes/macrophages which participated in the injured endometria.

We also previously demonstrated that mesenchymal stromal cells (MSCs) had made excellent progress in the repair of endometrial injury [19,20,21]. The studies revealed that MSCs directly interacted with various types of immune cells to maintain homeostasis in the injured tissues [22, 23]. However, to date, it is not reported on the regulation of MSCs on the efferocytosis and migration of LPMs in the injured endometria.

In the present study, we demonstrated that LPMs migrated to the uteri in response to the damage in early phase (3 h), and sustained to a later stage (7 days). Meanwhile, the proportion of ferroptotic monocytes/macrophages was significantly increased in the injured uteri since 12 h after injury. Through LPMs depletion assay in vivo and coculture systems in vitro, we found that LPM efferocytosis against ferroptotic monocytes/macrophages, and this process appeared an induction of glycolysis program and depended on the PPARγ-HK2 pathway. Furthermore, MSCs promoted the efferocytosis of LPMs to repair the injured uteri through secreting stanniocalcin-1 (STC-1). Collectively, our research demonstrated the essential functions of LPMs for endometrial repair and provided a novel mechanism of MSCs in repairing the injured endometria.

Methods

Reagents

Erastin (Catalog # HY-15,763), Cytochalasin D (Catalog # HY-N6682), 2-Deoxy-D-glucose (Catalog # HY-13,966), Rosiglitazone (Catalog # HY-17,386), T0070907 (Catalog # HY-13,202), and Bafilomycin A1 (Catalog # HY-100,558) were purchased from MedChem Express (Monmouth Junction, NJ, USA). MDA (Catalog # ab243066) was purchased from Abcam (Cambridge, MA, USA), ROS (Catalog # S0033S) was purchased from Beyotime (Shanghai, China), Recombinant human STC-1 (Catalog # 9400-S0-050) was purchased from R&D (Boston, MO, USA). Clodronate liposome was purchased from Liposoma B.V (Vrije University, Netherlands). LPS derived from Escherichia coli (Catalog # 0111: B4) was purchased from Sigma-Aldrich (St. Louis, MO, USA).

Cell cultures

THP-1 cells were cultured in 1640 (Gibco, Grand Island, NY, USA) containing 10% FBS (Gibco, Grand Island, NY, USA), 1% penicillin and streptomycin (100 µg/mL; Gibco, Grand Island, NY, USA), at 37 °C in a humidified atmosphere with 5% CO2.

Mouse peritoneal macrophages were obtained from 8- to 10-week-old female Balb/c mice as previously described [24]. Peritoneal macrophages were cultured in DMEM (Gibco, Grand Island, NY, USA) containing 10% FBS (Gibco, Grand Island, NY, USA), 1% penicillin and streptomycin (100 µg/mL; Gibco, Grand Island, NY, USA), at 37 °C in a humidified atmosphere with 5% CO2.

Human umbilical cord mesenchymal stem cells (hUC-MSCs) were purchased from the Nanjing Drum Tower Clinical Stem Cell Center. MSCs were cultured in Dulbecco’s modified Eagle’s medium/F12 (Gibco, Grand Island, NY, USA) supplemented with 1% penicillin and streptomycin (100 µg/mL; Gibco, Grand Island, NY, USA), and 10% FBS (Gibco, Australia origin). MSCs between passages 3 and 5 were used in subsequent experiments.

In vitro efferocytosis assays

THP-1 cells were treated with Erastin (80 µM) for 24 h and stained with CFSE (2.5 µg / 1 × 107 cells) (Catalog # 65-0850-85; Invitrogen, Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 10 min. Stained cells were collected by centrifugation at 300×g for 5 min. Peritoneal macrophages were incubated with CSFE-stained ferroptotic THP-1 cells at a ratio of 3:1 for 4 h. The MFI of CFSE in LPMs containing the ingested ferroptotic THP-1 cells was determined by flow cytometry or immunofluorescence assay.

Immunofluorescence assay

LPMs were incubated with CSFE-stained ferroptotic THP-1 cells. Cells were fixed in 4% paraformaldehyde and incubated in blocking buffer (5% BSA in PBS) for 1 h at room temperature. Cells were then incubated with rat anti-mouse CD102 (Catalog # 10121-2-AP; Proteintech, Wuhan, China) overnight at 4 ℃. After rinsing thrice with PBS, cells were incubated with Alexa Fluor 647 conjugated goat anti-rat IgG secondary antibody (Catalog # A21247; Invitrogen, Carlsbad, CA, USA) for 1 h at room temperature in the dark. Finally, nuclei were stained with DAPI (Bioworld Technology CO., Ltd., Nanjing, China) and observed under an FV3000 Laser Scanning Confocal Microscope (Olympus Corporation, Tokyo, Japan).

MSCs cocultured with macrophages

Indirect coculture

MSCs were seeded in the upper compartment of Transwells (0.4-µm pore size, Costar, Corning, Tewksbury, MA) in 24-well plates. LPMs were collected and cocultured with MSCs in the lower compartment of Transwells. LPMs were coincubated in the presence of LPS (100 ng/mL) for 24 h. The supernatants were collected for ELISAs, and LPMs were collected for qRT-PCR.

Direct coculture

LPMs were collected and cocultured with MSCs (MSCs: LPMs = 1:5) in the presence of LPS (100 ng/mL) for 24 h in standard 24-well plates. The supernatants were collected for ELISAs, and cells were collected for qRT-PCR.

Cell migration

MSCs were seeded in the lower compartment of Transwells (3-µm pore size, Costar, Corning, Tewksbury, MA) in 24-well plates. LPMs were seeded in the upper chamber in the presence of LPS (100 ng/mL) for 24 h. After removal of the culture solution in the upper chamber and three washes with PBS, the upper chamber was fixed with 4% paraformaldehyde for 15 min and three washes with PBS. Then, ammonium oxalate crystal violet was added to the upper chamber and dyed for 15 min, the dye liquor was recovered, the dye liquor was slowly washed away with PBS. Cotton swab was used in the upper chamber to absorb water. The chamber was placed on a slide glass, images were taken and quantification was performed.

Animals and experimental protocol

Healthy female Balb/c mice (8–10 weeks old) were obtained from Jiangsu Huachuang Xinnuo Pharmaceutical Technology Co., Ltd. (Taizhou, China), and they were housed under a standard 12 h/12 h light/ dark cycle. Mice had ad libitum access to food and water. All procedures involving mice were performed in strict accordance with protocols based on the Institutional Guidelines for Animal Care and Use and approved by the Animal Care Committee at Nanjing University (No. IACUC-D2202077).

The IUA murine model was established as previously described [17], dual methods using uterine curettage and Lipopolysaccharides (LPS) injection. In Result 1, mice were randomly divided into 14 groups, sham (3 h, 6 h, 12 h, 1 day, 2 day, 4 day, and 7 day), in which mice received only an incision wound without any treatment to the endometrium, and IUA groups (3 h, 6 h, 12 h, 1 day, 2 day, 4 day, and 7 day), which received curettage of bilateral intact endometrial with an intrauterine injection of LPS (1 mg/ml). In Result 1, the mice were intraperitoneally injected with 100 µL of clophosome A clodronate liposomes (CLL) into the abdominal cavity, followed by IUA. Mice were sacrificed on Day 2. In result 5, MSCs (1 × 106 cells in 200 µL of phosphate-buffered saline (PBS)) were intraperitoneally injected 4 days after IUA modelling. Mice were sacrificed on Day 7. In result 6, the mice were administered 100 µL of CLL on Day 3. After 24 h, these mice were randomly assigned to receive intraperitoneal injections of PBS or MSCs (1 × 106 cells/mouse). Mice were sacrificed on Day 7.

RNA isolation and quantitative real-time PCR

Total RNA was extracted from tissues or cells using TRIzol reagent (Vazyme Biotech, China), following the manufacturer’s instructions. 1 µg total RNA was reverse transcribed in a 20-µL reaction system using the HiScript ll Q RT SuperMix for qPCR (Catalogue # R222-01; Vazyme Biotech, China). Differences among the target gene expression levels were calculated by the ΔΔCt method and normalised to the level of β-actin. The primers used are listed in Supplementary Table 1.

Enzyme-linked immunosorbent assay (ELISA)

The protein levels of TNF-α, IL-1β, and IL-6 (BioLegend, SanDiego, CA, USA) in mouse serum, the protein level of TGF-β1 (Catalogue # KE10005; Proteintech, Wuhan, China) and STC-1 (Catalogue # EK1404; Boster, Wuhan, China) in the cell culture supernatants were detected using ELISA kits according to the manufacturer’s protocol.

Western blotting

Proteins in cells were extracted with RIPA lysis buffer (Beyotime Biotechnology). Protein concentrations were determined using the Bradford assay (Pierce Biotechnology, Waltham, MA, USA). An equal amount (30 mg) of the protein lysate was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and immunoblotted with the antibodies against HK2 (Catalogue # 2867 S; Cell Signaling Technology, Danvers, MA, USA).

Flow cytometry assay

CD11b (Catalog # 101,206; Biolegend, San Diego, CA, USA), F4/80 (Catalog # 17-4801-82; Invitrogen, Carlsbad, CA, USA), CD102 (Catalog # 742,107; BD Pharmingen, San Jose, CA, USA), MHCII (Catalog # 12-5321-82; eBioscience, San Diego, CA, USA), GPX4 (Catalog # NBP3-08253 V; Novus Littleton, CO, USA) were used for labeling cells. All flow cytometry data were acquired using the Beckman Coulter Cytoflex S (Beckman Coulter, CA, USA) or BD FACSCalibur cytometer (BD Biosciences, San Diego, CA, USA) and analyzed using FlowJo software (Treestar, Inc., San Carlos, CA, USA).

Cell viability assay

Cell Counting Kit-8 (CCK-8) assay was used according to the manufacturer’s instructions (Catalog # CK04, Dojindo, Tokyo, Japan).

Small interfering RNAs (siRNAs)

SiRNAs targeting HK2 and STC-1 were purchased from RiboBio (Guangzhou, China). Cells were transfected with 100 nM siRNA or nontargeting siRNA controls using RiboFECT CP Reagent (Ribobio, Guangzhou, China, Catalog No: C10511-05) according to the manufacturer’s instructions. SiRNA sequences were as follows: HK2: 5′-GCAACATCCTGATCGATTT-3′; STC-1: 5′-AGACCACTGTGCCCAAACA-3′. HK2 and STC-1 mRNA and protein expression levels were assessed by qRT-PCR and western blotting or ELISA, respectively.

Statistical analysis

All values in the graphs are presented as the mean ± SD. Unpaired Student’s t-tests were used to analyze the statistical significance. For all statistical tests, significance was set at p < 0.05. Data analysis was performed using GraphPad Prism 8.

Results

Migration of large peritoneal macrophages to the injured uteri is vital for the clearance of ferroptotic monocytes/macrophages in uteri

Uterus is located in cavity and LPMs rapidly migrate into the region of injury/inflammation where they contribute to tissue repair. To investigate the dynamic changes of LPMs in vivo, we conducted a mouse model of IUA (Fig. 1A). In the sham group, the mice underwent laparotomy without any treatment of the endometrium. Mice were sacrificed on 3 h, 6 h, 12 h, day 1, day 2, day 4, or day 7 after the surgery. The expressions of TNF-α, IL-1β, and IL-6 in uteri and serum were significantly up-regulated in IUA groups (Fig. 1B, C). We evaluated the percentages of LPMs in the peritoneal cavity and uteri by flow cytometry. Compared with sham groups, the percentages of LPMs in the peritoneal cavity of IUA groups decreased significantly at every point of time (Fig. 1D). Meanwhile, the percentages of LPMs in the IUA uteri significantly increased (Fig. 1E). And the most notable changes occurred in day 2 both in the peritoneal cavity and uteri.

Fig. 1
figure 1

Accumulation of large peritoneal macrophages following injury in the uteri. (A) Schematic of in vivo IUA mice model setup (n = 6–8). (B) The mRNA expression levels of TNF-α, IL-1β, and IL-6 in the endometria of mice were determined by qRT-PCR (normalised to β-actin). (C) Serum concentrations of TNF-α, IL-1β, and IL-6 were measured by ELISA. (D) Flow cytometry analysis for LPMs isolated from peritoneal cavity harvested at different time points after injury. Cells were pregated on CD11b+. (E) Flow cytometry analysis for LPMs isolated from uteri harvested at different time points after injury. (F) Immunohistochemical staining of MDA in the endometria of mice (scale bar: 100 μm). (G) Flow cytometry analysis for GPX4 expression of CD11b+F4/80med subsets in the uteri harvested at different time points after injury. (H) Schematic of in vivo LPMs depletion mice model setup (n = 6). (I) The mRNA expression levels of TNF-α, IL-1β, and IL-6 in the endometria of mice were determined by qRT-PCR (normalised to β-actin). (J) Serum concentrations of TNF-α, IL-1β, and IL-6 were measured by ELISA. (K) Flow cytometry analysis for LPMs isolated from peritoneal cavity harvested after 2-days injury. Cells were pregated on CD11b+. (L) Flow cytometry analysis for LPMs isolated from uteri harvested after 2-days injury. (M) Flow cytometry analysis for GPX4 expression of CD11b+F4/80med subsets in the uteri harvested after 2-days injury. Values are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns denotes p > 0.05 (by unpaired Student’s t test)

Full size image

Malondialdehyde (MDA) staining revealed increased iron deposition and lipid peroxidation in the endometria of IUA mice (Fig. 1F), suggesting ferroptosis occurred in endometria of IUA uteri. To identify the main cell type undergoing ferroptosis, we used the flow cytometry to distinguish LPMs from monocytes/macrophages in the uteri, the results revealed the presence of two distinct macrophage populations within the uteri. CD102 has been identified as a specific marker for LPMs [25]. Nearly half of the macrophages expressed CD102 in the CD11b+F4/80+ population, while the CD102 expression were almost all negative within the CD11b+F4/80med population, indicating that the LPMs were not present in CD11b+F4/80med population, which might be monocytes/macrophages originally existed in the uteri (Fig. 1G). GPX4 is the only antioxidant enzyme that can directly reduce phospholipid peroxidation in cells and plays an important role in ferroptosis [26]. We found interestingly that after 12 h, GPX4-negative cells gated in CD11b+F4/80med population significantly increased. These data indicated that monocytes/macrophages obviously underwent ferroptosis in the IUA uteri.

To detect whether LPMs that migrated to the uteri can engulf ferroptotic monocytes/macrophages, we injected intraperitoneally clodronate liposome (CLL) in advance to remove peritoneal macrophages (Fig. 1H). The expressions of TNF-α, IL-1β, and IL-6 in uteri and serum were significantly up-regulated in IUA + CLL group, compared with IUA + con-CLL group (Fig. 1I, J). Notedly, we found that when LPMs were depleted by CLL (Fig. 1K), the proportion of LPMs in the uteri decreased (Fig. 1L), while more importantly, the proportion of ferroptotic monocytes/macrophages in the uteri significantly increased (Fig. 1M). These results suggested that LPMs were responsible for the clearance of ferroptotic monocytes/macrophages in the injured endometria and inflammation resolution.

LPM efferocytosis are verified in clearing ferroptotic monocytes/macrophages in vitro

To induce ferroptosis in monocytes/macrophages, we stimulated the macrophage cell line THP-1 cells with Erastin and found that Erastin significantly downregulated the cell viability, upregulated the content of lactate dehydrogenase (LDH), MDA, ROS, and the mRNA expression of ferroptosis biomarker Ptgs2 in THP-1 cells (Fig. 2A-E). As ferroptosis coincided with morphologic changes, transmission electron microscopy studies revealed that Erastin induced mitochondrial cristae disappearance and outer membrane rupture in THP-1 cells (Fig. 2F).

Fig. 2
figure 2

Ferroptotic THP-1 cells promote the efferocytosis of LPMs in vitro. (A) Cell viability, (B) LDH relative content, and (C) the MDA concentration in THP-1 cells stimulated with different concentrations of Erastin for 24 h. (D) The intracellular ROS level stimulated with 80 µM Erastin for 24 h was measured by confocal microscope. (scale bar: 50 μm) (E) qRT-PCR analysis showed the mRNA level of Ptgs2 in THP-1 cells stimulated with 80 µM Erastin for 24 h (normalised to β-actin). (F) Representative pictures acquired by transmission electron microscopy. Red arrows indicated mitochondrial cristae disappearance and outer membrane rupture. (G) THP-1 cells treated with or without Erastin for 24 h, then stained by CFSE. MFI of CFSE in THP-1 cells was detected by flow cytometry. LPMs were incubated with nontreated or Erastin-treated THP-1 cells stained by CFSE for 4 h. (H, I) Efferocytosis of LPMs from each group was determined by (H) flow cytometry and (I) confocal microscope (scale bar: 50 μm). (J, K) LPMs pretreated with 5 µM CytoD for 1 h were incubated with nontreated or Erastin-treated THP-1 cells stained by CFSE for 4 h. Efferocytosis of LPMs from each group was determined by (J) flow cytometry and (K) confocal microscope (scale bar: 50 μm). (L) LPMs were incubated with nontreated or Erastin-treated THP-1 cells for 4 h. The mRNA levels of efferocytosis related genes in LPMs were measured by qRT-PCR (normalised to β-actin). Values are mean ± SD. *p < 0.05, **p < 0.01, ****p < 0.0001, ns denotes p > 0.05 (by unpaired Student’s t test)

Full size image

Given the fact that LPMs possess the ability of efferocytosis to clear the dead cells. We hypothesized that LPMs engulf ferroptotic THP-1 cells. To examine this hypothesis, THP-1 cells were treated with or without Erastin. Expectedly, Erastin induction did not affect the basal level of 5(6)-carboxyfluorescein diacetate N-succinimidyl ester (CFSE) in THP-1 cells (Fig. 2G), then LPMs incubated with ferroptotic THP-1 cells pre-stained with CFSE. The MFI of CFSE dramatically increased in LPMs cocultured with Erastin-treated THP-1 cells, compared with LPMs cocultured with nontreated THP-1 cells (Fig. 2H, I). By contrast, Cytochalasin D (an efferocytosis inhibitor) treatment significantly reversed the MFI of CFSE in LPMs cocultured with Erastin-treated THP-1 cells (Fig. 2J, K). It was reported that macrophages can recognize and bind phosphatidylserine (PS) directly through transmembrane receptors such as TIM4 on the membrane surface. The recognition of PS by the tyrosine kinase receptor family (AXL, MERTK, TAM) on the membrane surface is mediated by secreting GAS6 and protein S as bridge molecules [27,28,29]. We found that the mRNA expression levels of GAS6, MERTK, TIM4, and AXL were upregulated in LPMs cocultured with Erastin-treated THP-1 cells, compared with LPMs cocultured with nontreated THP-1 cells (Fig. 2L).

Efferocytosis is thought to promote the pro-resolving phenotype by down-regulating proinflammatory cytokines and increasing pro-resolving factors [30]. We found that both mRNA and secretion levels of TGF-β1 were significantly upregulated, while the expressions of pro-inflammatory factors TNF-α, IL-1β, and IL-6 were significantly downregulated in LPMs cocultured with Erastin-treated THP-1 cells (Supplementary Fig. 1A-D). The efferocytosis-induced macrophage resolution pathways are reported to be triggered by activation of apoptosis cell (AC) receptors or molecules resulting from the phagolysosomal degradation of engulfed Acs [31, 32]. So we pre-treated LPMs with bafilomycin A1 (Baf A1), a lysosomal vacuolar ATPase inhibitor that blocks phagolysosomal AC degradation during efferocytosis. We found that Baf A1 treatment suppressed Erastin-treated THP-1 cells-induced increase in TGF-β1 and decrease in IL-1β (Supplementary Fig. 1E, F). All together, these studies exhibited that Erastin-induced ferroptotic THP-1 cells enhanced the efferocytic capability of LPMs and promoted LPMs skewing themselves toward alternative or repair phenotype.

LPM efferocytosis against ferroptotic monocytes/macrophages depends on the PPARγ-HK2 pathway

To identify the pathways potentially involved in efferocytosis, we performed RNA sequencing of LPMs engulfing ferroptotic or control THP-1 cells (Fig. 3A). Efferocytic LPMs displayed changes in multiple genes (Fig. 3B). Gene Ontology (GO) enrichment analysis showed that many signal transduction pathways including glucose homeostasis and PPAR signaling pathway were activated (Fig. 3C). Cluster heatmap revealed upregulation of multiple glycolysis genes, with concurrent downregulation of TCA cycle genes (Fig. 3D). We further verified these changes of glycolysis genes via qRT-PCR, and found that HK2 was the most varied gene (Fig. 3E). Further, LPMs pre-treated with 2-deoxyglucose (2-DG, a competitive inhibitor of hexokinase that block glycolysis) showed decreased efferocytosis (Fig. 3F).

Fig. 3
figure 3

Transcriptional program is initiated during efferocytosis. (A) Schematic of in vitro coculture system setup. (B) The volcano figure showed fold-changes of genes in LPMs incubated with nontreated or Erastin-treated THP-1 cells. (C) GO enrichment analysis of all differentially expressed genes. (D) The thermogram of glycolysis and TCA cycle related genes expression pattern. (E) qRT-PCR analysis showed the glycolysis related genes in LPMs incubated with nontreated or Erastin-treated THP-1 cells for 4 h. LPMs pretreated with 10 mM 2-DG for 2 h were incubated with nontreated or Erastin-treated THP-1 cells stained by CFSE for 4 h (normalised to β-actin). (F) Efferocytosis of LPMs from each group was determined by flow cytometry. Values are mean ± SD. *p < 0.05, **p < 0.01, ****p < 0.0001 (by unpaired Student’s t test)

Full size image

Peroxisome proliferator-activated receptor γ (PPARγ), a nuclear receptor activated by oxidized lipids, is a driver of macrophage metabolic programs, enhancing the ability to take up and digest dying cells [33]. As expected, the expression of PPARγ was upregulated in efferocytic LPMs cocultured with ferroptotic THP-1 cells (Fig. 4A). The efferocytosis of LPMs was upregulated by treatment with the PPARγ agonist, Rosiglitazone, while downregulated by treatment with the PPARγ inhibitor, T0070907. Rosiglitazone or T0070907 did not affect the cell viability of LPMs (Fig. 4B-D). Especially, the expression of HK2 in LPMs was upregulated by pretreatment with Rosiglitazone, while downregulated by T0070907 (Fig. 4E). To validate HK2 in LPM efferocytosis, we knocked down the expression of HK2 in LPMs by siRNA (Fig. 4F, G), and found that siHK2 reversed the efferocytosis of LPMs enhanced by Rosiglitazone (Fig. 4H, I). These results indicated LPMs effectively phagocytized to eliminate ferroptotic monocytes/macrophages via the PPARγ-HK2 pathway.

Fig. 4
figure 4

The PPARγ-HK2 pathway promotes the efferocytosis of LPMs against ferroptotic THP-1 cells. (A) The mRNA expression level of PPARγ in LPMs incubated with nontreated or Erastin-treated THP-1 cells for 4 h (normalised to β-actin). (B) Cell viability of LPMs treated with 10 µM PPARγ agonist, Rosiglitazone or 10 µM PPARγ inhibitor, T0070907 for 18 h. (C, D) LPMs treated as above were incubated with nontreated or Erastin-treated THP-1 cells for 4 h. Efferocytosis of LPMs from each group was determined by (C) flow cytometry and (D) confocal microscope (scale bar: 50 μm). (E) The mRNA expression level of HK2 in LPMs treated as above was detected by qRT-PCR. (F, G) qRT-PCR analysis (F) and Western blotting (G) showed the mRNA and protein levels of HK2 in LPMs transfected with three interfering fragments of HK2 (si-HK2) for 24 h. Full-length blots are presented in Supplementary Fig. 6. (H, I) LPMs were transfected with siHK2 for 24 h before stimulated with 10 µM Rosiglitazone, then incubated with Erastin-treated THP-1 cells stained by CFSE for 4 h. Efferocytosis of LPMs from each group was determined by (H) flow cytometry and (I) confocal microscope (scale bar: 40 μm). Values are mean ± SD. *p < 0.05, **p < 0.01, ns denotes p > 0.05 (by unpaired Student’s t test).

Full size image

MSCs promote the efferocytosis of LPMs to repair the injured uteri

The cross-talk between MSCs and monocytes/macrophages is vital for the regulation of inflammation and repair, leading to the restoration of tissue homeostasis after injury. However, the effect of MSCs on LPMs needs to be unveiled. To mimic LPMs in the injured uteri, LPMs were pretreated with LPS, with or without MSCs for 24 h, then co-cultured with ferroptotic THP-1 cells (Fig. 5A). We found that MSCs significantly enhanced the efferocytosis of LPMs (Fig. 5B, C) and promoted polarization of LPMs to the M2 phenotype (Supplementary Fig. 2). The crystal violet assay showed that MSCs also promoted the migration ability of LPMs (Fig. 5D).

Fig. 5
figure 5

MSCs promote the efferocytosis and migration of LPMs to the injured uteri to repair the injured endometria. (A) Schematic of in vitro coculture system setup. (B, C) Efferocytosis of LPMs from each group was determined by (B) flow cytometry and (C) confocal microscope (scale bar: 50 μm). (D) Crystal violet staining of LPMs cocultured with MSCs or LPS (scale bar: 100 μm). (E) Schematic of in vivo experimental model design (n = 5–7). (F) Flow cytometry analysis for LPMs isolated from peritoneal cavity harvested after 7-days injury. Cells were pregated on CD11b+. (G) Flow cytometry analysis for LPMs isolated from uteri harvested after 7-days injury. (H) Flow cytometry analysis for GPX4 expression of CD11b+F4/80med subsets in the uteri harvested after 7-days injury. (I) HE, Masson’s trichrome staining, MDA, ER, and PR stainings of endometrial tissues obtained from mice of three groups. Scale bar indicates 100 μm. (J) The mRNA expression levels of TNF-α, IL-1β, and IL-6 in the endometria of mice were determined by qRT-PCR (normalised to β-actin). (K) Serum concentrations of TNF-α, IL-1β, and IL-6 were measured by ELISA. Values are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ns denotes p > 0.05 (by unpaired Student’s t test)

Full size image

Next, to detect the effects of MSCs on the regulation of the migration of LPMs and the therapeutic efficacy on the injured endometria in vivo, we established IUA mouse model (Fig. 5E). We found that MSCs significantly reduced the proportion of LPMs in the peritoneal cavity but increased the proportion of LPMs in the uteri. Deservedly, the proportion of ferroptotic monocytes/macrophages was reduced in the uteri (Fig. 5F-H). Importantly, MSCs drastically mitigated uterine pathological changes, including the increase of glands and the reduction of collagen deposition. MSCs also decreased the level of MDA in the endometrial stroma of IUA mice. Estrogen receptor (ER) and progesterone receptor (PR) are indicators of endometrial recovery in IUA [34]. The expressions of ER and PR were significantly increased in the MSCs-treated group compared with that in the IUA group (Fig. 5I). Meanwhile, MSCs reduced the expressions of inflammatory factors TNF-α, IL-1β, and IL-6 in the uteri and serum (Fig. 5J, K). To explore whether MSCs exerted their effects through LPMs, we injected intraperitoneally CLL to deplete LPMs before MSCs treatment (Fig. 6A) and found that the effects of MSCs were inhibited by LPMs depletion (Fig. 6B-E).

Fig. 6
figure 6

MSCs exert the effect of repairing the injured endometria through LPMs. (A) Schematic of in vivo experimental model design (n = 6–8). (B) Flow cytometry analysis for LPMs isolated from peritoneal cavity harvested after 7-days injury. Cells were pregated on CD11b+. (C) Flow cytometry analysis for LPMs isolated from uteri harvested after 7-days injury. (D) Flow cytometry analysis for GPX4 expression of CD11b+F4/80med subsets in the uteri harvested after 7-days injury. (E) HE staining, Masson’s trichrome staining, and MDA staining of endometrial tissues obtained from mice of four groups. Scale bar indicates 100 μm. (F) The mRNA expression levels of TNF-α, IL-1β, and IL-6 in the endometria of mice were determined by qRT-PCR (normalised to β-actin). (G) Serum concentrations of TNF-α, IL-1β, and IL-6 were measured by ELISA. Values are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (by unpaired Student’s t test)

Full size image

These data confirmed that MSCs alleviated endometrial injury through LPMs, which migrated into the uteri and exerted its efferocytosis against ferroptotic monocytes/macrophages in the injured uteri.

STC-1 is necessary for MSCs to promote the efferocytosis of LPMs

To search for MSC-derived factors affecting the efferocytosis of LPMs, we detected MSCs-secreted prominent molecules that affect the macrophage phenotype, including stanniocalcin-1 (STC-1), hepatocyte growth factor (HGF), tumor necrosis factor (TNF)-stimulated gene and protein 6 (TSG-6), vascular endothelial growth factor (VEGF), and transforming growth factor-β1 (TGF-β1). When MSCs cocultured with LPS-stimulated LPMs relative to LPS or LPMs alone, the mRNA and protein levels of STC-1 were just upregulated in MSCs (Fig. 7A, B), while the changes of HGF, TSG-6, VEGF, and TGF-β1 were not impressive (Supplementary Fig. 3). Moreover, rhSTC-1 significantly enhanced the efferocytosis of LPMs (Fig. 7C, D). Contrarily, when STC-1 was knocked down in MSCs by siRNA (Fig. 7E, F), siSTC-1 could reverse the MSCs-enhanced efferocytosis of LPMs (Fig. 7G, H). Furthermore, in vivo studies revealed that STC-1 deficiency in MSCs also reversed the effect of MSCs on LPM efferocytosis as well as alleviation of endometrial fibrosis (Fig. 7I-O). These results revealed that the promotion of MSCs on LPM efferocytosis was in an STC-1-dependent manner.

Fig. 7
figure 7

MSCs promote the efferocytosis of LPMs by secreting STC-1 in vitro and in vivo. (A, B) The mRNA (A) and protein (B) levels of STC-1 in MSCs cocultured with LPMs stimulated with LPS for 24 h were determined by qRT-PCR and ELISA (normalised to GAPDH). (C, D) LPMs were incubated with nontreated or Erastin-treated THP-1 cells in the presence of rhSTC-1 protein (100 ng/mL) for 4 h. Efferocytosis of LPMs from each group was determined by (C) flow cytometry and (D) confocal microscope (scale bar: 40 μm). (E, F) qRT-PCR analysis (E) and ELISA (F) showed the mRNA and protein levels of STC-1 in MSCs transfected with three interfering fragments of STC-1 (si-STC-1) for 24 h (normalised to GAPDH). (G, H) MSCs were transfected with siSTC-1 for 24 h before cocultured with LPMs, then LPMs were incubated with Erastin-treated THP-1 cells stained by CFSE for 4 h. Efferocytosis of LPMs from each group was determined by (G) flow cytometry and (H) confocal microscope (scale bar: 40 μm). (I) Schematic of in vivo experimental model design (n = 5–7). (J) Flow cytometry analysis for LPMs isolated from peritoneal cavity harvested after 7-days injury. Cells were pregated on CD11b+. (K) Flow cytometry analysis for LPMs isolated from uteri harvested after 7-days injury. (L) Flow cytometry analysis for GPX4 expression of CD11b+F4/80med subsets in the uteri harvested after 7-days injury. (M) HE staining, Masson’s trichrome staining, and MDA staining of endometrial tissues obtained from mice of four groups. Scale bar indicates 100 μm. (N) The mRNA expression levels of TNF-α, IL-1β, and IL-6 in the endometria of mice were determined by qRT-PCR (normalised to β-actin). (O) Serum concentrations of TNF-α, IL-1β, and IL-6 were measured by ELISA. Values are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ns denotes p > 0.05 (by unpaired Student’s t test)

Full size image

Discussion

Mature LPMs reside in the peritoneum with a less alternatively activated state, but once activated by signals derived from injury, they can be rapidly induced to express molecules associated with an alternative activated phenotype, which are thought to have tissue repair properties, showing decreased production of pro-inflammatory cytokines and increased production of immunosuppressive cytokines [9, 35]. Our results suggested that Erastin-induced ferroptotic THP-1 cells enhanced LPM efferocytosis and promoted LPMs skewing themselves toward alternative or repair phenotype, since the level of pro-resolving factor-TGF-β1 was significantly upregulated, while the expressions of pro-inflammatory factors TNF-α, IL-1β, and IL-6 were significantly downregulated in LPMs cocultured with Erastin-treated THP-1 cells (Supplementary Fig. 1A-D). Early activation of alternative activated LPMs may accelerate the end of inflammation and guarantee a rapid repair to preserve tissue integrity. Meanwhile, in the peritoneal cavity, LPMs also skew their phenotype toward alternative or repair macrophages, increasing their expression of arginase 1, decreasing their expressions of TNF-α, IL-1β, and IL-6 since 3 h after injury (supplementary Fig. 4), which may be attributed to the opening of the abdominal cavity and LPMs may also repair injury in the abdominal cavity.

LPMs process the ability to phagocytose apoptotic or necrotic cells [36, 37]. The clearance of these dead cells appeared to be vital for revascularization and restoration of normal tissue. Indeed, in our study, the proportion of ferroptotic monocytes/macrophages in the uteri was increased and the inflammation was aggravated once LPMs were depleted (Fig. 1G-M). Administration of CLL greatly reduced the proportion of LPMs in the peritoneal cavity but did not affect the proportion of ferroptotic monocytes/macrophages in the endometria. In addition, there was a decrease in the proportion of macrophages in abdominal organs such as spleen, while there were no significant differences in the proportion of macrophages in bone marrow and liver (supplementary Fig. 5). In vitro, Erastin-induced ferroptotic THP-1 cells enhanced the efferocytosis of LPMs (Fig. 2H-I).

It is generally believed that efferocytic macrophages are more M2-like [38], M2-like macrophages are reported to be OXPHOS-dependent, but Morioka S et al. reported that efferocytosis induced a metabolic gene program promoting glucose uptake and subsequent glycolysis, with downregulation of genes related to OXPHOS and FAO in the first few hours. Although glycolysis is linked to inflammation, they found that efferocytic phagocytes can affect non-engulfing naive macrophages towards anti-inflammatory polarization by releasing factors such as TGFβ and IL-10 during efferocytosis [39]. In consistent with this study, our work revealed that efferocytic LPMs engulfing ferroptotic THP-1 cells displayed changes in multiple genes (Fig. 3B), promoting multiple glycolysis genes, with concurrent downregulation of TCA cycle genes (Fig. 3D). Meanwhile, efferocytosis resulted in pro-repair phenotype of LPMs, with an induction of TGF-β1 and reduction of pro-inflammation factors TNF-α, IL-1β, and IL-6 (supplementary Fig. 1).

Like other tissue resident macrophages, LPMs perform an important immune surveillance function, maintaining healthy tissues by removing dead and dying cells and toxic materials. But LPMs also migrate to neighboring viscera in the peritoneal cavity such as liver and colon and help repairing damaged tissues [7, 40,41,42]. Tissue resident macrophages such as alveolar macrophages, Kupffer cells, microglia, osteoclasts, and LPMs all have specialized functions and phenotypes, local tissue-derived signals control the development of tissue-specific phenotypes [43, 44]. Studies reported that zinc finger transcription factor GATA6 uniquely expresses in LPMs, but not other macrophage subsets, regulates a tissue-specific gene expression program in LPMs, controls a subset of LPMs functions, including controlling anatomical localization of LPMs and IgA production by B-1 cells [7]. B-1 cells are a subtype of B cells, distributed uniquely in the peritoneal cavity and almost absent in lymphoid tissues. B-1 cells in peritoneal cavity continuously migrate to intestinal lamina propria, where they give rise to IgA-secreting cells [45, 46]. GATA6 in LPMs regulates gut IgA response mediated by peritoneal B-1 cells.

The cross-talk between MSCs and macrophages is vital for the regulation of inflammation and repair, leading to the restoration of tissue homeostasis after injury [47]. To comprehensively understand how MSCs affect LPMs upon injury, we analyzed the effects of MSCs on polarization, migration, and efferocytosis of LPMs under stress by using a coculture system of LPMs activated with LPS. We found that MSCs instructed LPMs to fulfill homeostatic functions through promoting anti-inflammatory polarization and migration into the injured uteri, and enhancing the efferocytosis of LPMs (Fig. 5).

The knowledge of regulatory factors from MSCs on the efferocytosis of LPMs was limited until now. There are several studies reported the substances of MSCs on the regulation of macrophage efferocytosis. Gómez-Ferrer M et al. found that extracellular vesicles derived from MSCs significantly improved the ability of monocyte-derived M1 macrophages to clear apoptotic neutrophils [48]. Zhang M et al. reported that exosomal miR‑16 and miR‑21 derived from bone marrow MSCs primed macrophages isolated from MRL‑lpr mice kidney for high efferocytosis activity, anti-inflammatory cytokines secretion, and Treg cell recruitment/differentiation [49]. Di Carlo SE et al. demonstrated that metabolically altered ADAM12+MSCs induced pathological angiogenesis and immunosuppression by promoting efferocytosis and polarization of BMDMs through overexpression of genes such as Gas6, Lgals3 and Csf1 [50]. Li LL et al. reported that adipose-derived MSCs reduced the activation of NLRC4 inflammasome in THP-1 cells induced by pseudomonas aeruginosa infection through the secretion of STC-1, thereby increasing the phagocytic ability of macrophages, and ultimately improving lung tissue damage [51]. A high-through assaying to identify regulatory factors from MSCs on the efferocytosis of LPMs will be useful and help to find the factor with the most significant regulatory effect, which will be carried out in our future studies.

STC-1 is a glycoprotein hormone expressed in various organs and tissues of the human body [52]. Studies have shown that STC-1 promotes cell proliferation and angiogenesis, reduces oxidative stress, and inhibits inflammation [53, 54]. It has been reported that STC-1 plays an important role in the immune regulation of MSCs [51, 55,56,57,58]. MSCs-derived STC-1 was required and sufficient for reduction of apoptosis of lung cancer epithelial cells [55]. STC-1 secreted by human umbilical MSCs can promote the secretion of IL-10 in alveolar macrophages, thus alleviating the inflammatory storm caused by acute respiratory distress syndrome [56]. Adipose-derived MSCs reduced the activation of NLRC4 inflammasome in macrophages induced by pseudomonas aeruginosa infection through the secretion of STC-1, thereby increasing the phagocytic ability of macrophages, and ultimately improving lung tissue damage [51]. In the present study, we found that MSCs expressed high levels of STC-1 when co-cultured with LPMs with LPS activation. STC-1 knockdown experiments showed that STC-1 deficiency in MSCs reversed the effect of MSCs on the regulation of LPMs and alleviation of endometrial fibrosis (Fig. 7I-O), which implied that STC-1 was an effector molecule of MSCs.

LPMs exert multiple functions after injury through efferocytosis, anti-inflammatory polarization, and suppression of other immune cells. As described in the present study, we revealed that LPMs were directed by MSCs to the injured endometria, so that to achieve homeostatic functions, promote the clearance of endometrial ferroptotic monocytes/macrophages and be vital effectors in inflammation and resolution.

Conclusion

In summary, we demonstrated that LPMs migrated into the injured endometria to eliminate ferroptotic monocytes/macrophages. LPM efferocytosis can be promoted by MSCs-secreted STC-1. Collectively, our research demonstrated the essential functions of LPMs for endometrial repair and provided a novel mechanism of MSCs in repairing the injured endometria.

Data availability

All data generated or analyzed during study are included in the article.

Abbreviations

IUA:

Intrauterine adhesions

LPMs:

Large peritoneal macrophages

MSCs:

Mesenchymal stromal cells

CLL:

Clodronate liposomes

PBS:

Phosphate-buffered saline

LPS:

Lipopolysaccharides

GO:

Gene Ontology

MDA:

Malondialdehyde

LDH:

Lactate dehydrogenase

CFSE:

5(6)-carboxyfluorescein diacetate N-succinimidyl ester

PS:

Phosphatidylserine

AC:

Apoptosis cell

Baf A1:

Bafilomycin A1

PPARγ:

Peroxisome proliferator-activated receptorγ

2-DG:

2-deoxyglucose

ER:

Estrogen receptor

PR:

Progesterone receptor

STC-1:

Stanniocalcin-1

HGF:

Hepatocyte growth factor

TSG-6:

Tumor necrosis factor

TNF:

stimulated gene and protein 6

VEGF:

Vascular endothelial growth factor

TGF-β1:

Transforming growth factor-β1

References

  1. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome–one century later. Fertil Steril. 2008;89(4):759–79.

    Article  PubMed  Google Scholar 

  2. Kelleher AM, Milano-Foster J, Behura SK, Spencer TE. Uterine glands coordinate on-time embryo implantation and impact endometrial decidualization for pregnancy success. Nat Commun. 2018;9(1):2435.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A. 2010;107(6):2568–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bain CC, Hawley CA, Garner H, Scott CL, Schridde A, Steers NJ, et al. Long-lived self-renewing bone marrow-derived macrophages displace embryo-derived cells to inhabit adult serous cavities. Nat Commun. 2016;7:ncomms11852.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kim KW, Williams JW, Wang YT, Ivanov S, Gilfillan S, Colonna M, et al. MHC II + resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytes. J Exp Med. 2016;213(10):1951–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Goudot C, Coillard A, Villani AC, Gueguen P, Cros A, Sarkizova S, et al. Aryl Hydrocarbon receptor controls monocyte differentiation into dendritic cells versus macrophages. Immunity. 2017;47(3):582–e5966.

    Article  CAS  PubMed  Google Scholar 

  7. Wang J, Kubes P. A Reservoir of mature cavity macrophages that can rapidly invade visceral organs to affect tissue repair. Cell. 2016;165(3):668–78.

    Article  CAS  PubMed  Google Scholar 

  8. Deniset JF, Belke D, Lee WY, Jorch SK, Deppermann C, Hassanabad AF, et al. Gata6 + pericardial cavity macrophages relocate to the injured heart and prevent Cardiac Fibrosis. Immunity. 2019;51(1):131–e1405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. J Cell Biol. 2010;189(7):1059–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhu Q, Yao S, Ye Z, Jiang P, Wang H, Zhang X, et al. Ferroptosis contributes to endometrial fibrosis in intrauterine adhesions. Free Radic Biol Med. 2023;205:151–62.

    Article  CAS  PubMed  Google Scholar 

  11. Zou L, Huang J, Zhang Q, Mo H, Xia W, Zhu C, et al. The humanin analogue (HNG) alleviates intrauterine adhesions by inhibiting endometrial epithelial cells ferroptosis: a rat model-based study. Hum Reprod. 2023;38(12):2422–32.

    Article  CAS  PubMed  Google Scholar 

  12. Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death Nexus linking metabolism, Redox Biology, and Disease. Cell. 2017;171(2):273–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wu J, Liu Q, Zhang X, Tan M, Li X, Liu P, et al. The interaction between STING and NCOA4 exacerbates lethal sepsis by orchestrating ferroptosis and inflammatory responses in macrophages. Cell Death Dis. 2022;13(7):653.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Liu W, Östberg N, Yalcinkaya M, Dou H, Endo-Umeda K, Tang Y, et al. Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. J Clin Invest. 2022;132(13):e155724.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Cao D, Zheng J, Li Z, Yu Y, Chen Z, Wang Q. ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model. Arthritis Res Ther. 2023;25(1):212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang J, Li D, Pan Y, Li J, Jiang Q, Liu D, et al. Interleukin-34 accelerates intrauterine adhesions progress related to CX3CR1 + monocytes/macrophages. Eur J Immunol. 2021;51(10):2501–12.

    Article  CAS  PubMed  Google Scholar 

  18. Lv H, Sun H, Wang L, Yao S, Liu D, Zhang X, et al. Targeting CD301 + macrophages inhibits endometrial fibrosis and improves pregnancy outcome. EMBO Mol Med. 2023;15(9):e17601.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Jiang Q, Li J, Pan Y, Wang J, Yang J, Shen S, et al. Melatonin-primed MSCs alleviate intrauterine adhesions by affecting MSC-Expressed Galectin-3 on macrophage polarization. Stem Cells. 2022;40(10):919–31.

    Article  PubMed  Google Scholar 

  20. Li J, Pan Y, Yang J, Wang J, Jiang Q, Dou H, et al. Tumor necrosis factor-α-primed mesenchymal stem cell-derived exosomes promote M2 macrophage polarization via Galectin-1 and modify intrauterine adhesion on a novel murine model. Front Immunol. 2022;13:945234.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Yao S, Zhou Z, Wang L, Lv H, Liu D, Zhu Q, et al. Targeting endometrial inflammation in intrauterine adhesion ameliorates endometrial fibrosis by priming MSCs to secrete C1INH. iScience. 2023;26(7):107201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Naji A, Favier B, Deschaseaux F, Rouas-Freiss N, Eitoku M, Suganuma N. Mesenchymal stem/stromal cell function in modulating cell death. Stem Cell Res Ther. 2019;10(1):56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cselenyák A, Pankotai E, Horváth EM, Kiss L, Lacza Z. Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol. 2010;11:29.

    Article  PubMed  PubMed Central  Google Scholar 

  24. LiJ,PanY,LiD,XiaX,JiangQ,DouH,etal.Urokinase-type plasminogen activator receptor is required for impairing toll-like receptor 7 signaling on macrophage efferocytosis in lupus.Mol Immunol.2020;127:38–45.

  25. Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell. 2014;157(4):832–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144–52.

    Article  CAS  PubMed  Google Scholar 

  27. Luo B, Gan W, Liu Z, Shen Z, Wang J, Shi R, et al. Erythropoeitin Signaling in Macrophages promotes dying cell clearance and Immune Tolerance. Immunity. 2016;44(2):287–302.

    Article  CAS  PubMed  Google Scholar 

  28. Luo X, Gong HB, Gao HY, Wu YP, Sun WY, Li ZQ, et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 2021;28(6):1971–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Wen Q, Liu J, Kang R, Zhou B, Tang D. The release and activity of HMGB1 in ferroptosis. Biochem Biophys Res Commun. 2019;510(2):278–83.

    Article  CAS  PubMed  Google Scholar 

  30. Ampomah PB, Cai B, Sukka SR, Gerlach BD, Yurdagul A Jr, Wang X, et al. Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution. Nat Metab. 2022;4(4):444–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20(4):254–67.

    Article  CAS  PubMed  Google Scholar 

  32. Morioka S, Maueröder C, Ravichandran KS. Living on the Edge: efferocytosis at the interface of Homeostasis and Pathology. Immunity. 2019;50(5):1149–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Fernandez-Boyanapalli RF, Falcone EL, Zerbe CS, Marciano BE, Frasch SC, Henson PM, et al. Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment. J Allergy Clin Immunol. 2015;136(5):1399–e14013.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wang J, Ju B, Pan C, Gu Y, Zhang Y, Sun L, et al. Application of bone marrow-derived mesenchymal stem cells in the Treatment of Intrauterine Adhesions in rats. Cell Physiol Biochem. 2016;39(4):1553–60.

    Article  CAS  PubMed  Google Scholar 

  35. Salm L, Shim R, Noskovicova N, Kubes P. Gata6 + large peritoneal macrophages: an evolutionarily conserved sentinel and effector system for infection and injury. Trends Immunol. 2023;44(2):129–45.

    Article  CAS  PubMed  Google Scholar 

  36. Cocco RE, Ucker DS. Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell. 2001;12(4):919–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kelly B, O’Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015;25(7):771–84.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Gaber T, Strehl C, Buttgereit F. Metabolic regulation of inflammation. Nat Rev Rheumatol. 2017;13(5):267–79.

    Article  PubMed  Google Scholar 

  39. Morioka S, Perry JSA, Raymond MH, Medina CB, Zhu Y, Zhao L, et al. Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature. 2018;563(7733):714–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Bain CC, Jenkins SJ. The biology of serous cavity macrophages. Cell Immunol. 2018;330:126–35.

    Article  CAS  PubMed  Google Scholar 

  41. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity. 2002;16(1):67–76.

    Article  CAS  PubMed  Google Scholar 

  42. Roberts AW, Lee BL, Deguine J, John S, Shlomchik MJ, Barton GM. Tissue-Resident macrophages are locally programmed for silent clearance of apoptotic cells. Immunity. 2017;47(5):913–e9276.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953–64.

    Article  CAS  PubMed  Google Scholar 

  44. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11(1):34–46.

    Article  CAS  PubMed  Google Scholar 

  46. Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol. 2010;28:243–73.

    Article  CAS  PubMed  Google Scholar 

  47. Ko JH, Kim HJ, Jeong HJ, Lee HJ, Oh JY. Mesenchymal stem and stromal cells harness macrophage-derived amphiregulin to maintain tissue homeostasis. Cell Rep. 2020;30(11):3806–e38206.

    Article  CAS  PubMed  Google Scholar 

  48. Gómez-Ferrer M, Amaro-Prellezo E, Dorronsoro A, et al. HIF-Overexpression and pro-inflammatory priming in human mesenchymal stromal cells improves the Healing properties of Extracellular vesicles in experimental Crohn’s Disease. Int J Mol Sci. 2021;22(20):11269.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Zhang M, Johnson-Stephenson TK, Wang W, et al. Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17 + regulatory T cell. Stem Cell Res Ther. 2022;13(1):484.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Di Carlo SE, Raffenne J, Varet H, et al. Depletion of slow-cycling PDGFRα + ADAM12 + mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis. Nat Immunol. 2023;24(11):1867–78.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Li LL, Zhu YG, Jia XM, et al. Adipose-derived mesenchymal stem cells ameliorating Pseudomonas aeruginosa-induced Acute Lung infection via inhibition of NLRC4 inflammasome. Front Cell Infect Microbiol. 2021;10:581535.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Yeung BH, Law AY, Wong CK. Evolution and roles of stanniocalcin. Mol Cell Endocrinol. 2012;349(2):272–80.

    Article  CAS  PubMed  Google Scholar 

  53. Bonfante S, Della Giustina A, Danielski LG, Denicol T, Joaquim L, Biehl E, et al. Stanniocalcin-1 ameliorates cerebral ischemia by decrease oxidative stress and blood brain barrier permeability. Microvasc Res. 2020;128:103956.

    Article  PubMed  Google Scholar 

  54. Bonfante S, Joaquim L, Fileti ME, Giustina AD, de Souza Goldim MP, Danielski LG, et al. Stanniocalcin 1 inhibits the inflammatory response in Microglia and protects against Sepsis-Associated Encephalopathy. Neurotox Res. 2021;39(2):119–32.

    Article  CAS  PubMed  Google Scholar 

  55. Block GJ, Ohkouchi S, Fung F, et al. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells. 2009;27(3):670–81.

    Article  CAS  PubMed  Google Scholar 

  56. Xia TT, Hu R, Shao CJ, et al. Stanniocalcin-1 secreted by human umbilical mesenchymal stem cells regulates interleukin-10 expression via the PI3K/AKT/mTOR pathway in alveolar macrophages. Cytokine. 2023;162:156114.

    Article  CAS  PubMed  Google Scholar 

  57. Zhang R, Liu Q, Zhou S, He H, Zhao M, Ma W. Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1. Elife. 2023;12:e82934.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Luo R, Li L, Liu X, et al. Mesenchymal stem cells alleviate palmitic acid-induced endothelial-to-mesenchymal transition by suppressing endoplasmic reticulum stress. Am J Physiol Endocrinol Metab. 2020;319(6):E961–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the National Key R&D Program of China (2023YFC2308200) and the Key Research and Development Program of Jiangsu Province (BE2019706).

Author information

Authors and Affiliations

  1. The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, No. 22 Hankou Rd., Gulou District, Nanjing, Jiangsu, 210093, People’s Republic of China

    Jiali Wang, Jingman Li, Lijie Yin, Xiuzhu Wang, Yue Dong, Sunan Shen & Yayi Hou

  2. Department of Obstetrics and Gynecology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China

    Guangfeng Zhao

  3. Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, 210093, China

    Sunan Shen & Yayi Hou

Authors
  1. Jiali Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingman Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lijie Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiuzhu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yue Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guangfeng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sunan Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yayi Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

WJL and HYY designed the experiments. WJL performed the experiments. WJL, LJM, and YLJ analysed data. WXZ DY ZGF participated in the interpretation and writing of the manuscript, ZGF and SSN supervised the research. HYY and WJL wrote and revised the manuscript. All authors participated in the paper preparation and approved the final paper submission. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Sunan Shen or Yayi Hou.

Ethics declarations

Ethics approval and consent to participate

All procedures involving mice were performed in strict accordance with protocols based on the Institutional Guidelines for Animal Care and Use and approved by the Animal Care Committee at Nanjing University (No. IACUC-D2202077). Title of the approved project: Role and mechanism of a new subgroup of AREG+ large peritoneal macrophages in intrauterine adhesions. Date of approval:24 February, 2022.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Li, J., Yin, L. et al. MSCs promote the efferocytosis of large peritoneal macrophages to eliminate ferroptotic monocytes/macrophages in the injured endometria. Stem Cell Res Ther 15, 127 (2024). https://doi.org/10.1186/s13287-024-03742-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13287-024-03742-z

Keywords

Stem Cell Research & Therapy

ISSN: 1757-6512